Introducing NICE Advice

This week, the National Institute for Health, and Care Excellence (NICE) has launched its refreshed support service for the life sciences sector, NICE Advice. The service will provide accurate and reliable scientific and strategic advice, education, and NHS insights to pharmaceutical and Healthtech companies. It aims to help companies succeed, so that more patients gain access to the best treatments and care. 

NICE Advice offers life science companies the same valued scientific advice and health system engagement meetings provided by NICE’s previous support services, NICE Scientific Advice, and the Office for Market Access.

However, it is now much easier to access, through one single service and a refreshed website. It offers greater flexibility to everyone using it. Healthtech companies will also benefit from a more tailored support offer, that is more closely aligned to their pace of development and budget. 

As England’s health technology assessment body and the only national body to appraise individual medicines or devices, NICE possesses a unique position. It provides trusted, unrivalled expertise in health technology assessment and holds unique NHS insight and experience. Through NICE Advice, this is drawn upon to support life science companies to effectively demonstrate the value of their product. Thereby helping to drive innovation into the hands of health and care professionals.

NICE Advice offers 3 types of support, which can be tailored to the needs and budget of individual companies, whatever your stage of development:

• Advice - Identifying gaps in evidence, providing actionable technical scientific advice on clinical and economic evidence plans, and quality-checking economic models.
• Insight – facilitating access to valuable insight, ranging from a 1-hour session with a NICE expert to a 2-3-hour health system engagement meeting with a range of experts. Insight gained can help identify a suitable path to market or address complex market access challenges.
• Education – A range of free webinars and paid seminars, delivered online or in-person. These cover a broad range of topics relating to NICE’s work including evidence generation, health economic modelling, NICE evaluations and other topics in the world of health technology assessment and evidence-based healthcare. 

These services are confidential and are provided independently of NICE's guidance producing programmes to ensure there are no conflicts of interest.

Mark Chapman, interim director of medical technology and digital evaluation at NICE, said: “NICE Advice provides a single point of contact for individuals and organisations across the life sciences sector. By coming to us, they’ll gain access to accurate, reliable and actionable advice, NHS insights and education they can trust. We want to help companies succeed, so that more patients gain access to the best treatments and care.” 

Jeanette Kusel, director of NICE Advice, said: “NICE Advice can help companies prepare for a technology appraisal, or engagement with payers or commissioners. Engaging with us can help save time and money and get innovations into the hands of health and care professionals faster. If you’re unsure about working with NICE, I’d encourage you to come and talk to us.”

To find out more you can submit an enquiry online or visit the NICE Advice website.

 

More news and updates